| Interest of EMDR Schizophrenic Disorders (NCT05164289) | Hôpital NOVO | 2021-12-10 |
| Neuropsychological Assessment of Remediation for Cognitive Impairments in Schizophrenia (NCT04608032) | Centre hospitalier de Ville-Evrard, France | 2020-09-08 |
| Have a Good Grasp of the Worldthe World (NCT02655172) | Centre Hospitalier Universitaire de Saint Etienne | 2016-05-24 |
| Sodium Butyrate For Improving Cognitive Function In Schizophrenia (NCT02654405) | Nathan Kline Institute for Psychiatric Research | 2016-04-01 |
| Upside Down, Give me the Handle (NCT02544516) | Centre Hospitalier Universitaire de Saint Etienne | 2014-04-01 |
| A Study Measuring Effect of LY2140023 (Pomaglumetad Methionil) on Electrocardiographs in Participants With Schizophrenia (NCT01606436) | Denovo Biopharma LLC | 2012-06-01 |
| Effectiveness of a Physical Activity and Diet Program in Patients With Psychotic Disorder (CapiCor) (NCT01729650) | Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | 2012-06-01 |
| D-amino Acid Oxidase Inhibition (DAAOI-1) add-on Treatment for Chronic Schizophrenia (NCT00960219) | China Medical University Hospital | 2009-04-01 |
| Clozapine/Paliperidone Versus Clozapine/Placebo in Resistant Schizophrenia (NCT01279213) | Universidad Nacional de Rosario | 2009-01-01 |
| Study in Schizophrenic In-patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible Dose (NCT00660595) | AstraZeneca | 2008-09-01 |
| Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to Risperidone (NCT00600756) | AstraZeneca | 2008-01-01 |
| Interest of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Auditory Hallucinations (NCT02525315) | University Hospital, Caen | 2007-06-01 |
| Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia. (NCT00488319) | Janssen Research & Development, LLC | 2007-06-01 |
| The Psychiatric Rehabilitation Approach to Weight Loss (NCT00572247) | University of Kansas | 2007-01-01 |
| Sarcosine Preventive Therapy for Individuals At High Risk for Schizophrenia (NCT00276263) | Herzog Hospital | 2006-08-01 |
| Sarcosine or D-Serine Add-on Treatment for Chronic Schizophrenia (NCT00491569) | China Medical University Hospital | 2005-01-01 |
| Sarcosine (N-Methylglycine) Monotherapy for Schizophrenia (NCT00328276) | China Medical University Hospital | 2004-12-01 |
| Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in Patients With Schizophrenia (NCT00088491) | Eli Lilly and Company | 2004-06-01 |
| Assessment of a Weight Management Program for Weight Gain in Patients With Schizophrenia (NCT00485823) | Eli Lilly and Company | 2002-12-01 |